Neuronetics Inc expected to post a loss of 12 cents a share - Earnings Preview

Neuronetics

02/05/2025 14:36

Neuronetics Inc STIM.OQ STIM.O is expected to show a rise in quarterly revenue when it reports  results on May 6 for the period ending March 31 2025

The Malvern Pennsylvania-based  company is expected to report a 66.9% increase in revenue to $29.068 million from $17.42 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.The company's guidance on March 4 2025, for the period ended March 31, was for revenue between $28.00 million and $30.00 million.

​LSEG's mean analyst estimate for Neuronetics Inc is for a loss of 12 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Neuronetics Inc is $7.00​, above​ its last closing price of $4.46. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.25
-0.21
-0.33
Missed
-57.1
Sep. 30 2024
-0.23
-0.23
-0.44
Missed
-91.3
Jun. 30 2024
-0.27
-0.27
-0.33
Missed
-22.2​
Mar. 31 2024
-0.32
-0.31
-0.27
Beat
12.9
​​Dec. 31 2023
-0.26
-0.26
-0.19
Beat
27.3
Sep. 30 2023
-0.31
-0.31
-0.33
Missed
-6.7​
Jun. 30 2023
-0.35
-0.35
-0.17
Beat
51.2
Mar. 31 2023
-0.39
-0.39
-0.38
Beat
2.1

This summary was machine generated May 2 at 13:36 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)